Q3 FY2026 · ended Sep 30, 2026 · Revenue $2.98B, +5.0% YoY · Filed Oct 29, 2026
Baxter International Inc. (BAX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $3.0 billion and net income of $294.0 million. As of Sep 30, 2026 it held $2.0 billion in cash and investments and $206.0 million in total debt.
Revenue
$2.98B
+5.0% vs year-ago quarter
Net income
$294.00M
+739.1% vs year-ago quarter
Operating cash flow
$558.00M
+135.4% vs year-ago quarter
Free cash flow
—
EPS
$0.57
+733.3% vs year-ago quarter
Dividend per share
$0.01
-94.1% vs year-ago quarter
Shares outstanding
517.35M
+0.6% vs year-ago quarter
Net cash
$1.77B
Q3 FY2026
Operating margin
-1.9%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BAX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Deerfield, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 10456
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.0B | $3.0B | $2.7B | $3.0B | $2.8B |
| Operating income | $225.0M | $217.0M | $66.0M | -$729.0M | $172.0M |
| Net income | $294.0M | $126.0M | -$15.0M | -$1.1B | -$46.0M |
| Diluted EPS | $0.57 | $0.24 | -$0.03 | -$2.21 | -$0.09 |
| Operating cash flow | $558.0M | $285.0M | $213.0M | $584.0M | $237.0M |
| Total assets | $19.4B | $19.8B | $19.8B | $20.1B | $21.1B |
| Total liabilities | $12.9B | $13.6B | $13.8B | $14.0B | $13.9B |
| Stockholders' equity | $6.5B | $6.2B | $6.0B | $6.1B | $7.2B |
| Cash and investments | $2.0B | $2.2B | $2.0B | $2.0B | $1.7B |
| Total debt | $206.0M | $208.0M | $224.0M | $9.8B | $214.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 29, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 19, 2026 | Aug 18, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 18, 2026 | Aug 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 4, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Other events
|
Aug 4, 2026 | Aug 4, 2026 |
All 1001 Baxter International Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.